The comparison of combination SSRI and PDE-5 inhibitor therapy to SSRI monotherapy in men with premature ejaculation;Comparación de la combinación de SSRI e inhibidores de la PDE-5 con SSRI en monoterapia para el tratamiento de la eyaculación precoz

Annals of Pharmacotherapy

Volumn 45, Issue 7-8, 2011, Pages 1000-1004

  Burton, Travis D ^a   Liday, Cara ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

Phosphodiesterase 5 inhibitor; Premature ejaculation; Selective serotonin reuptake inhibitor

Indexed keywords

FLUOXETINE; LIDOCAINE; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TADALAFIL;

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EJACULATION; EJACULATION DISORDER; FLUSHING; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LATENT PERIOD; LIBIDO; MALE; MEDLINE; MONOTHERAPY; NAUSEA; PREMATURE EJACULATION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SIDE EFFECT; TREATMENT DURATION; TREATMENT WITHDRAWAL;

ADULT; DRUG COSTS; DRUG THERAPY, COMBINATION; EJACULATION; FLUSHING; HEADACHE; HUMANS; MALE; PATIENT SATISFACTION; PHOSPHODIESTERASE 5 INHIBITORS; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TIME FACTORS;

EID: 79960801307     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q008     Document Type: Article

References (16)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., text revision. Washington, DC: American Psychiatric Association Publishing, 2000.
3. World Health Organization. The ICD -10 classification of mental and behavioral disorders diagnostic criteria for research. http://www.who.int/classifications/icd/en/GRNBOOK.pdf (accessed 2010 Aug 28).
4. Waldinger MD, Quinn O, Dilleen MS, et al. A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2005;2:492-497.
5. Waldinger MD. Recent advances in the classification, neurobiology and treatment of premature ejaculation. Adv Psychosom Med 2008;29:50-69.
6. Bettocc C, Verze P, Palumbo F, et al. Ejaculatory disorders: pathophysiol-ogy and management. Nat Clin Pract Urol 2008;5:93-103.
7. Masters WH, Johnson VE. Premature ejaculation. In: Masters WH, Johnson VE, eds. Human sexual inadequacy. Boston: Little, Brown, 1970:92-115.
8. Waldinger MD, Zwinderman AH, Schweitzer DH, et al. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 2004;16:369-381.
9. Montague DK, Jarow J, Broderick GA, et al. American Urological Association guideline on the pharmacologic management of premature ejaculation. J Urol 2004;172:290-294.
10. Abdel-Hamid IA, El Naggar EA, El Gilany AH. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001;13:41-45.
11. Wang WF, Wang Y, Minhas S, et al. Can sildenafil treat primary premature ejaculation? A prospective clinical study. Int J Urol 2007;14:331-335.
12. Salonia A, Maga T, Renzo C. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002;168:2486-2489.
13. Hosseini MM, Yarmohammadi H. Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation. Urol Int 2007;79:28-32.
14. Mattos RM, Lucon AM, Srougi M. Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. Urol Int 2008;80:163-165.
15. Chen J, Mabjeesh NJ, Matzkin H, et al. Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology 2003;61:197-200.
16. Manasia P, Pomerol J, Ribe N et al. Comparison of the efficacy and safety of 90 mg versus 20 mg fluoxetine in the treatment of premature ejaculation. J Urol 2003;170:164-165.